Gregory Rossi
Impact in
- Hematology top 2%
- Erythropoietin and Anemia Treatment
- Iron Metabolism and Disorders
- Biochemistry top 5%
- Blood transfusion and management
Papers in
- Hematology 11
- Erythropoietin and Anemia Treatment 11
- Iron Metabolism and Disorders 2
-
- Pharmacological Effects and Toxicity Studies 4
- Co-authors
- Kerry Taylor (2 shared papers)David I. Watson (2 shared papers)Michael Hedenus (2 shared papers)Alan Colowick (4 shared papers)Jesús F. San Miguel (1 shared paper)Eeva Juvonen (1 shared paper)Martin R. Schipperus (1 shared paper)Albert Altés (1 shared paper)
- Journals
- Expert Opinion on Biological Therapy (2 papers)Cancer (2 papers)British Journal of Haematology (2 papers)Expert Review of Pharmacoeconomics & Outcomes Research (1 paper)PubMed (4 papers)
- Partner nations
- United StatesBelgiumUnited Kingdom
In The Last Decade
Gregory Rossi
12 papers receiving 561 citations
Peers
Comparison fields: 5 of 41
- Hematology 499
- Biochemistry 94
- Genetics 66
- Oncology 90
- Pediatrics, Perinatology and Child Health 56
Countries citing papers authored by Gregory Rossi
This map shows the geographic impact of Gregory Rossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Rossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Rossi more than expected).
Fields of papers citing papers by Gregory Rossi
This network shows the impact of papers produced by Gregory Rossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Rossi. The network helps show where Gregory Rossi may publish in the future.
Co-authors
The 25 scholars most cited alongside Gregory Rossi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 267 | |
| 2 | 2002 | 76 | |
| 3 | 2003 | 69 | |
| 4 | Assessment of hematologic effects and fatigue in cancer patients with chemotherapy-induced anemia given darbepoetin alfa every two weeks. | 2006 | 56 |
| 5 | 2004 | 40 | |
| 6 | Clinical trial simulation of a 200-microg fixed dose of darbepoetin alfa in chemotherapy-induced anemia. | 2002 | 18 |
| 7 | Every-2-week darbepoetin alfa is comparable to rHuEPO in treating chemotherapy-induced anemia. Results of a combined analysis. | 2002 | 16 |
| 8 | 2013 | 14 | |
| 9 | Darbepoetin alfa: impact on treatment for chemotherapy-induced anemia and considerations in special populations. | 2002 | 11 |
| 10 | 2003 | 10 | |
| 11 | Every-2-Week Darbepoetin Alfa Is Comparable to rHuEPO in Treating Chemotherapy-Induced Anemia | 2002 | 10 |
| 12 | 2003 | 1 |
About Gregory Rossi
Gregory Rossi is a scholar working on Hematology, Pediatrics, Perinatology and Child Health, Genetics, Biochemistry and Immunology, having authored 12 papers that have together received 588 indexed citations. Recurring topics across this work include Erythropoietin and Anemia Treatment (11 papers), Pharmacological Effects and Toxicity Studies (4 papers), Hemoglobinopathies and Related Disorders (3 papers), Biosimilars and Bioanalytical Methods (3 papers), Blood transfusion and management (3 papers), Statistical Methods in Clinical Trials (2 papers), Iron Metabolism and Disorders (2 papers) and 3D Printing in Biomedical Research (1 paper). The work is most often cited by research in Hematology (499 citations), Biochemistry (94 citations), Genetics (66 citations), Oncology (90 citations) and Pediatrics, Perinatology and Child Health (56 citations). Gregory Rossi has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include Kerry Taylor, David I. Watson, Michael Hedenus, Alan Colowick, Jesús F. San Miguel, Eeva Juvonen, Martin R. Schipperus, Albert Altés, Magnus Adriansson and James Matcham. Their work appears in journals such as Expert Opinion on Biological Therapy, Cancer, British Journal of Haematology, Expert Review of Pharmacoeconomics & Outcomes Research and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.